BACKGROUND Vascular calcification is a major risk factor for cardiovascular morbidity and mortality in patients with end stage renal disease (ESRD). In Western countries, Blacks with ESRD appear to have lesser degrees of vascular calcification compared to non-Blacks. However, there is no published data on the association of ethnic differences in vascular calcification and survival in ESRD from Sub-Saharan Africa. METHODS This study assessed the 5-year change in vascular calcification and mortality in a previously published cohort of patients with ESRD. Vascular calcification was assessed by abdominal aortic calcification score (lateral abdominal radiograph) and vascular stiffness by pulse wave velocity. RESULTS Sixty-six of the original 74 participants, studied a baseline, were identified. The median age was 46.6 years (37.6-59.2) and 57.6% were women. Abdominal aortic calcification showed no progression among Blacks [baseline range 0-5, follow up range 0-8 (p=1.00)], but a nonsignificant trend to progression among non-Blacks [baseline range 0-19, follow up range 0-22 (p=0.066)]. Black participants did not display a survival advantage (p=0.870). Overall, sepsis was the most common cause of mortality (64% of those with an identifiable cause of death). Non-Blacks had higher parathyroidectomy rates than Blacks with 9/30 cases compared to 2/36 (p=0.036). After adjustment for parathyroidectomy at follow up, the odds ratio of having abdominal vascular calcification score of ≥1 amongst non-Blacks was 8.6-fold greater compared to Blacks (p= 0.03). Central aortic systolic pressures (CASP) and pulse wave velocities (PWV) were higher in the study population than age matched normative values. At follow up, a positive correlation (r=0.3) was observed between PWV and abdominal aortic calcification (p=0.04). Elevated baseline coronary artery calcification score and FGF-23 level at baseline were not associated with a difference in mortality. CONCLUSION There was no significant progression in vascular calcification among Blacks. After adjusting for increased parathyroidectomy rates, there was a greater progression of vascular calcification amongst non-Blacks compared to Blacks highlighting possible ethnic differences in calcium phosphate metabolism in patients with ESRD. The lack of vascular calcification progression in Blacks was not however associated with improved survival, but the sample size was small.

Gallstones have been linked to dyslipidemia, metabolic syndrome and cardiovascular disease. Arterial stiffness is an indicator of subclinical atherosclerosis. The aim of this study was to prospectively examine the relationship between gallstone disease and arterial stiffness progression in 347 men and 454 women. These subjects were followed for 7 years. Arterial stiffness progression was measured based on increases in brachial-ankle pulse wave velocity. Changes in brachial-ankle pulse wave velocity during the study period were significantly greater in patients with gallstones than in subjects without gallstones. After adjusting for multiple risk factors, gallstone disease was found to be a significant and independent predictor of brachial-ankle pulse wave velocity progression (β=0.189; P<0.001). In conclusion, gallstone disease is an independent predictor of arterial stiffness progression, even after adjusting for other cardiovascular risk factors.

No description available.

No description available.

No description available.

BACKGROUND: Electronic cigarettes (e-cigarettes) are nicotine delivery systems that generate an aerosol that can be inhaled and come in a variety of attractive designs and e- liquid flavorings. E-cigarettes are the second most commonly used tobacco product in the United States and are predominantly used by youth and young adults. The cardiovascular health risk of combustible cigarette use is well-established, but whether e-cigarettes increase the risk of cardiovascular events is less clear. Evaluating the short-term vascular effects of e-cigarette use is an approach to gain insight into the cardiovascular health impact. Limited studies have shown that acute e-cigarette use in combustible cigarette users was associated with increased central hemodynamic values and arterial stiffness. Few studies have assessed the effects of chronic e-cigarette use on arterial stiffness, particularly in young adults. OBJECTIVE: To assess the effects of e-cigarette use on central hemodynamics and arterial stiffness in regular e-cigarette users in comparison to combustible cigarette users and non-users. METHODS: Combustible cigarette users, e-cigarette users, and non-users without known cardiovascular disease (CVD) or CVD risk factors between the ages of 18 and 45 were enrolled in the ongoing Cardiovascular Injury due to Tobacco Products 2.0 (CITU 2.0) study at the Boston University School of Medicine and the University of Louisville School of Medicine starting from 2019. Non-invasive arterial tonometry, using the SphygmoCor system, was performed to measure peripheral artery waveforms to obtain central hemodynamic values and arterial stiffness parameters: augmentation index (AIx), carotid-radial (CR) and carotid-femoral pulse wave velocities (CFPWV). RESULTS: We had available arterial stiffness measures in 209 study participants (mean age 26±7, 48% female) across 3 tobacco product use groups: combustible cigarette users (N=51), e-cigarette users (N=97), and non-users (N=61). Amongst the e-cigarette users, 41 were dual users (use of both e-cigarettes and combustible cigarettes), 25 were exclusive e-cigarette users who were former combustible cigarette users, and 31 were exclusive e-cigarette users who were never combustible cigarette users. The majority (87%) of e-cigarette users used a pod-based product with fruit and mint/wintergreen or menthol as the most popular e-liquid flavors. In unadjusted analyses, central systolic blood pressure, AIx, CRPWV, and CFPWV differed across the three tobacco product use categories. In multivariable regression models adjusting for age, sex, race and study site, e-cigarette users and combustible cigarette users had higher central systolic blood pressure (β=3.9±2.0, p=0.048 and β=4.8±2.4, p=0.04, respectively) whereas combustible cigarette smokers also had higher central AIx, and CRPWV compared to non-users (β=6.9±3.3, p=0.04 and β=0.97±0.31, p=0.002, respectively). In unadjusted analyses across the five groups, we found similar patterns of differences in vascular measures. In multivariable regression models comparing to combustible cigarette users, dual product users had similar measures of vascular function whereas exclusive e-cigarette users who were former smokers had lower CRPWV (β=-0.95±0.36, p=0.009), and exclusive e- cigarette users who were never combustible cigarette users had lower AIx (β=-9.0±4.2, 0.04). CONCLUSIONS: Our findings suggest that in young adults, combustible cigarette use is associated with measures of arterial stiffness. Dual e-cigarette use was largely similar to combustible cigarette use whereas exclusive e-cigarette use had a lesser degree of vascular stiffening. Further studies are needed to evaluate the long-term impact of e- cigarette use on cardiovascular health.

The purpose of our work is to estimate arterial stiffness based on the virtual fields method and using pressure gradients and arterial wall motion. Currently, the gold standard to estimate arterial stiffness relies primarily on the pulse wave velocity, which provides a relation between arterial stiffness and the velocity of the pressure wave propagating through the arterial wall. The pulse wave velocity method has been improved over the years, but still depends on specific assumptions regarding, for example, blood pressure, arterial geometry, and linear material response. The proposed method directly links arterial wall displacements and pressure gradients to arterial stiffness and paves the way to computing arterial stiffness with higher accuracy.

No description available.

No description available.

This diploma thesis deals with the variability of pulse wave velocity. It studies the variability of cardiovascular signals. It presents the research of measurement of pulse wave velocity and its analysis in physiology and pathological physiology. Applies spectral analysis in Matlab to a data set. It evaluates and reviews the results of this analysis